-
CGTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Cognition Therapeutics (CGTX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 22.01 mm | 22.01 mm | 22.01 mm | 22.01 mm | 22.01 mm | 22.01 mm |
Cash burn (monthly) | 2.17 mm | 913.17 k | 4.82 mm | 4.87 mm | 2.28 mm | 2.13 mm |
Cash used (since last report) | 11.01 mm | 4.63 mm | 24.42 mm | 24.67 mm | 11.57 mm | 10.78 mm |
Cash remaining | 11.00 mm | 17.39 mm | -2.41 mm | -2.65 mm | 10.44 mm | 11.23 mm |
Runway (months of cash) | 5.1 | 19.0 | -0.5 | -0.5 | 4.6 | 5.3 |
13F holders | Current |
---|---|
Total holders | 47 |
Opened positions | 20 |
Closed positions | 1 |
Increased positions | 5 |
Reduced positions | 5 |
13F shares | Current |
---|---|
Total value | 7.54 bn |
Total shares | 20.72 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
BIOS Memory SPV I | 6.01 mm | $6.85 mm |
BIOS Capital Management | 6.00 mm | $4.21 bn |
Pathstone Family Office | 2.21 mm | $2.47 mm |
Hirschman Orin | 1.45 mm | $3.40 mm |
Vanguard | 1.24 mm | $868.94 mm |
Sigma Planning | 614.49 k | $430.94 mm |
Alyeska Investment | 500.00 k | $350.65 mm |
Voss Capital | 500.00 k | $350.65 mm |
Geode Capital Management | 352.35 k | $247.14 mm |
AFG American Financial | 205.00 k | $143.77 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Feb 25 | John Brendan Doyle | Common Stock | Payment of exercise | Dispose F | No | No | 0.5901 | 1,723 | 1.02 k | 414,402 |
15 Feb 25 | Anthony Caggiano | Common Stock | Payment of exercise | Dispose F | No | No | 0.5901 | 5,296 | 3.13 k | 418,554 |
15 Feb 25 | Lisa Ricciardi | Common Stock | Payment of exercise | Dispose F | No | No | 0.5901 | 6,619 | 3.91 k | 887,066 |
4 Feb 25 | John Brendan Doyle | Common Stock | Grant | Acquire A | No | No | 0 | 295,000 | 0.00 | 416,125 |
4 Feb 25 | Anthony Caggiano | Common Stock | Grant | Acquire A | No | No | 0 | 295,000 | 0.00 | 423,850 |
3 Feb 25 | Anthony Caggiano | Common Stock | Payment of exercise | Dispose F | No | No | 0.666 | 12,779 | 8.51 k | 128,850 |